Condition: Alopecia Areata · Sponsor: Forte Biosciences, Inc.
This is a randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of FB102 in patients with severe to very severe alopecia areata (AA).
This description comes directly from the study's public registry record.
Support Officer · +61 3 7050 1941 · recruitment@clinibase.com
Always discuss trial participation with your own doctor first.
| St Leonards | Saint Leonards, New South Wales (nsw), Australia | Not Yet Recruiting |
| Coorparoo | Coorparoo, Queensland, Australia | Recruiting |
| South Yarra | South Yarra, Victoria, Australia | Not Yet Recruiting |
| Auckland | Auckland, Auckland, New Zealand | Not Yet Recruiting |
| Christchurch | Christchurch, Canterbury, New Zealand | Not Yet Recruiting |
| Palmerston North | Palmerston North, Palmerston North Central, New Zealand | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07205159